FDA LabelsFeb 2026
Why Most People Can't Read Their Own Prescription Labels
FDA drug labels are written for healthcare professionals, not patients. We break down what each section actually means and why the language matters.
Articles
Drug transparency, explained.
Plain language breakdowns of how drug data works, what government databases actually contain, and what the numbers mean.
VAERSJan 2026
VAERS Data Gets Misused Constantly. Here's How to Read It Right.
Anyone can submit a VAERS report, and a report alone doesn't prove a vaccine caused a side effect. Understanding how passive reporting works is critical before drawing conclusions.
RecallsJan 2026
The FDA Recall System Has Three Classes. Most People Only Hear About One.
Class I recalls grab headlines, but Class II and III happen far more often. What the classification actually tells you about risk.
Clinical TrialsDec 2025
What Happens in a Phase 3 Clinical Trial
Phase 3 is where a drug proves it works in large groups of people. But the process is more nuanced than 'it passed' or 'it failed.'
IngredientsDec 2025
Inactive Ingredients Aren't Always Harmless
Fillers, dyes, and preservatives can trigger allergic reactions in some patients. A look at which inactive ingredients to watch for and why they're in your medication.
Data InfrastructureNov 2025
How RxNorm Connects Every Drug Database in the Country
There's no single ID for 'ibuprofen' across government databases. RxNorm solves that by assigning each drug a universal concept identifier.
Adverse EventsNov 2025
The Difference Between an Adverse Event and a Side Effect
These terms get used interchangeably, but they mean different things. An adverse event is any bad outcome reported after taking a drug, whether or not the drug caused it.
PolicyOct 2025
Drug Pricing Transparency: What's Changed Since 2022
Recent federal rules now require hospitals and insurers to publish negotiated prices. How that data is shaping public awareness of drug costs.
FDA ProcessOct 2025
Why Some Drugs Get Approved Faster Than Others
The FDA has several accelerated approval pathways for serious conditions. Breakthrough therapy, fast track, and priority review each work differently.
Open DataSep 2025
Open Government Data Is Only Useful If People Can Actually Find It
The FDA, NIH, and CDC maintain dozens of public databases. The problem isn't access, it's discoverability. Most people don't know these resources exist.
FDA LabelsSep 2025
Generic vs. Brand Name Drugs: What's Actually Different
Generics have the same active ingredient, dosage, and strength as the brand version. The differences are in inactive ingredients, appearance, and price. Here's what the FDA requires.
Adverse EventsAug 2025
How to Read an FDA Adverse Event Report Without Panicking
Seeing thousands of adverse event reports for a common drug like ibuprofen sounds alarming. But context matters. More prescriptions means more reports, regardless of how safe the drug is.
FDA ProcessAug 2025
What 'Off-Label' Prescribing Means and Why It's Legal
Doctors can legally prescribe FDA-approved drugs for conditions they weren't specifically approved for. It happens more often than you think, and there are good reasons for it.
VaccinesAug 2025
The Childhood Vaccine Schedule Explained, Year by Year
The CDC recommends over a dozen vaccines before age 6. We walk through each one, when it's given, what it prevents, and why the timing matters.
FDA LabelsJul 2025
Black Box Warnings: The Strongest Safety Label the FDA Can Require
A boxed warning is the most serious warning on a prescription drug label. It means the drug carries significant risks that could affect prescribing decisions. Here's how they work.
RecallsJul 2025
Why Drug Recalls Don't Always Make the News
The FDA processes hundreds of recalls every year. Most are Class II or III and never reach mainstream media. Understanding recall volume helps put individual recalls in perspective.
Clinical TrialsJul 2025
How Clinical Trials Get Funded and Why That Matters
Most clinical trials are funded by pharmaceutical companies, but some are funded by the NIH or academic institutions. The funding source can influence what gets studied and how results are reported.
Data InfrastructureJun 2025
PubChem Has Data on 116 Million Compounds. Here's How to Use It.
PubChem is one of the largest open chemistry databases in the world. It's free, it's public, and it can tell you the molecular makeup of almost any drug on the market.
FDA ProcessJun 2025
What Happens After a Drug Gets FDA Approval
Approval isn't the end of the road. Phase 4 trials, post-market surveillance, and ongoing adverse event monitoring continue for the life of the drug.
Adverse EventsJun 2025
The Most Commonly Reported Side Effects Across All Drugs
Nausea, headache, dizziness, and fatigue appear in adverse event reports for almost every drug. Why these symptoms dominate the data and what that tells us.
VaccinesMay 2025
How the COVID-19 Vaccines Were Tested So Quickly
The COVID vaccines went through the same Phase 1, 2, and 3 trial process as other vaccines. What changed was the timeline, not the standards. Here's how overlapping phases and emergency funding made it possible.
FDA LabelsMay 2025
Drug Interactions: Why Your Pharmacist Asks What Else You Take
Some drug combinations can reduce effectiveness, amplify side effects, or create dangerous reactions. FDA labels include interaction data, but most patients never see it.
Clinical TrialsMay 2025
What 'Statistically Significant' Actually Means in a Clinical Trial
A result being statistically significant doesn't mean it's medically important. Understanding p-values and confidence intervals helps you evaluate trial results without being misled.
PolicyApr 2025
Why the Same Drug Costs $8 in One Country and $300 in Another
Drug pricing varies wildly across countries due to patent law, government negotiation, and market exclusivity. The U.S. is one of the few countries where manufacturers set their own prices.
IngredientsApr 2025
Vaccine Adjuvants: What They Are and Why They're Needed
Adjuvants are ingredients added to vaccines to strengthen the immune response. Aluminum salts have been used safely for decades. Here's what the data shows.
Adverse EventsApr 2025
How FAERS Data Gets Collected and Who Submits Reports
Pharmaceutical companies are required to report adverse events. Doctors and patients can report voluntarily. The mix of mandatory and voluntary reporting shapes the data in important ways.
FDA ProcessMar 2025
The FDA Doesn't Actually Test Drugs. Here's Who Does.
The FDA reviews data submitted by drug manufacturers and independent researchers. It sets the standards and evaluates the evidence, but the testing itself is done externally.
Data InfrastructureMar 2025
What NDC Codes Are and Why Every Drug Package Has One
The National Drug Code is a unique identifier assigned to every drug product sold in the U.S. It encodes the manufacturer, product, and package size in a single number.
PolicyFeb 2025
Biosimilars Are Not Generics. Here's the Difference.
Generic drugs are chemically identical copies. Biosimilars are close but not exact copies of biologic drugs made from living cells. The approval process and pricing implications are completely different.